V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270018850 | 270008100 | 1.8 | 97 | Neo-adjuvant (N) | 2017-03-29 | 2019-07-24 | Capecitabine | N | N | 270011793 | CAPECITABINE |
| 270018851 | 270008103 | 1.85 | 93.6 | Palliative (P) | 2017-03-05 | 2017-03-12 | Capecitabine + Oxaliplatin 21day | 02 | N | 270011807 | CAPECITABINE + OXALIPLATIN |
| 270018852 | 270016583 | null | 76 | Palliative (P) | null | 2016-11-09 | Brentuximab | null | N | 270011813 | BRENTUXIMAB |
| 270018853 | 270008119 | 1.81 | 49 | Curative (C) | 2015-01-13 | 2015-06-03 | Capecitabine | 02 | Y | 270011881 | CAPECITABINE |
| 270018854 | 270008122 | 1.77 | 114 | Palliative (P) | 2014-10-04 | 2014-11-15 | Capecitabine + Oxaliplatin 21day | N | N | 270011884 | CAPECITABINE + OXALIPLATIN |
| 270018855 | 270008130 | 1.71 | 66.7 | Palliative (P) | 2017-01-21 | 2017-06-18 | Brentuximab | 02 | N | 270011914 | BRENTUXIMAB |
| 270018856 | 270008137 | 1.85 | 94.8 | Palliative (P) | 2016-04-13 | 2016-05-21 | Capecitabine | N | N | 270011920 | CAPECITABINE |
| 270018857 | 270008141 | 1.73 | 97 | Not known (9) | 2014-08-16 | 2014-08-16 | Capecitabine | N | N | 270011935 | CAPECITABINE |
| 270018858 | 270013880 | null | 88 | Adjuvant (A) | null | 2015-06-17 | Capecitabine | N | null | 270011962 | CAPECITABINE |
| 270018859 | 270008158 | 1.86 | 77.25 | Disease modification (D) | 2014-12-07 | 2014-12-23 | Cetuximab 14 day | 02 | null | 270011982 | CETUXIMAB |
| 270018861 | 270019586 | 1.67 | 58.55 | Palliative (P) | null | 2018-01-23 | Cetuximab 14 day | 02 | N | 270012061 | CETUXIMAB |
| 270018862 | 270008181 | 1.8 | null | null | 2014-05-11 | 2014-05-11 | BEACOPP | N | N | 270012076 | BEACOPP |
| 270018863 | 270013896 | 0 | 97.6 | null | 2016-08-03 | 2016-08-03 | COPP + Dacarbazine | 02 | N | 270012090 | COPP + DACARBAZINE |
| 270018864 | 270008193 | null | 53.3 | Palliative (P) | 2014-04-26 | 2014-05-09 | CETUXIMAB | 02 | N | 270012098 | CETUXIMAB |
| 270018865 | 270013904 | null | null | Curative (C) | 2016-07-31 | 2016-10-12 | COPP + Dacarbazine | null | N | 270012138 | COPP + DACARBAZINE |
| 270018866 | 270008206 | null | 53.8 | Curative (C) | null | 2016-09-06 | HD EuroNet-PHL-C1 COPDAC | 2 | N | 270012147 | TRIAL |
| 270018867 | 270008213 | null | 69.4 | Neo-adjuvant (N) | 2015-05-06 | 2015-05-16 | Cetuximab 7 day (>Cycle 2) | N | Y | 270012174 | CETUXIMAB |
| 270018868 | 270008218 | null | null | Curative (C) | 2014-07-04 | 2014-09-13 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012187 | TRIAL |
| 270018869 | 270016619 | 1.63 | 72 | Curative (C) | 2015-04-28 | 2015-05-03 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270012207 | TRIAL |
| 270018870 | 270008260 | 0 | 59.6 | Curative (C) | 2016-07-01 | 2016-08-31 | Trial Unspecified | 1 | null | 270012302 | TRIAL |
| 270018871 | 270008264 | 1.81 | 83.7 | null | 2015-11-20 | 2016-02-21 | BEACOPP | N | N | 270012303 | BEACOPP |
| 270018872 | 270008268 | 0 | 67 | Palliative (P) | 2015-04-22 | 2015-06-24 | Trial Unspecified | 2 | Y | 270012310 | TRIAL |
| 270018873 | 270008271 | null | 56.6 | Palliative (P) | 2015-08-27 | 2015-10-29 | Trial Unspecified | N | N | 270012323 | TRIAL |
| 270018874 | 270008275 | 0 | 53.8 | Curative (C) | null | 2015-07-01 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012334 | TRIAL |
| 270018875 | 270008279 | 1.79 | 94.7 | null | 2013-04-27 | 2014-01-27 | Cetuximab 14 day | 2 | null | 270012345 | CETUXIMAB |
| 270018876 | 270013929 | 1.88 | 56.8 | Curative (C) | 2017-02-03 | 2017-04-04 | COPP + Dacarbazine | N | null | 270012347 | COPP + DACARBAZINE |
| 270018877 | 270008287 | 1.62 | 134.35 | Curative (C) | 2016-10-14 | 2016-12-04 | BEACOPP-14 | 02 | N | 270012371 | BEACOPP |
| 270018878 | 270008291 | 0 | 43.8 | Curative (C) | 2014-06-06 | 2014-10-31 | Cetuximab 14 day | null | N | 270012381 | CETUXIMAB |
| 270018879 | 270013939 | null | 54.9 | Curative (C) | 2015-10-13 | 2015-12-26 | Cetuximab 7 day (>Cycle 2) | N | N | 270012431 | CETUXIMAB |
| 270018880 | 270008314 | 1.63 | 66 | null | 2015-03-17 | 2015-03-18 | BEACOPP | 02 | N | 270012461 | BEACOPP |
| 270018881 | 270008318 | null | 59 | Curative (C) | null | 2016-10-05 | HD EuroNet-PHL-C1 COPDAC | null | N | 270012463 | TRIAL |
| 270018882 | 270008333 | 1.8 | 81 | Curative (C) | 2015-08-03 | 2015-08-06 | BEACOPP | N | N | 270012501 | BEACOPP |
| 270018883 | 270008344 | null | null | Adjuvant (A) | 2014-04-02 | 2014-04-02 | Trial Unspecified | 02 | N | 270012525 | TRIAL |
| 270018884 | 270008355 | 1.6 | 27.1 | Curative (C) | 2015-10-29 | 2015-10-30 | Escalated BEACOPP | 2 | N | 270012548 | BEACOPP |
| 270018885 | 270008361 | 1.67 | 39.3 | null | 2017-04-28 | 2017-06-27 | COPP + Dacarbazine | 02 | N | 270012569 | COPP + DACARBAZINE |
| 270018886 | 270008364 | 1.75 | 115 | Palliative (P) | 2014-01-15 | 2014-02-05 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270012579 | TRIAL |
| 270018887 | 270016644 | 0 | null | Curative (C) | 2017-03-05 | 2017-03-09 | HD EuroNet-PHL-C1 COPDAC | Y | null | 270012583 | TRIAL |
| 270018888 | 270008370 | 1.66 | 57.65 | Curative (C) | 2017-09-18 | 2017-11-06 | CETUXIMAB | N | N | 270012592 | CETUXIMAB |
| 270018889 | 270008375 | 0 | 16.4 | Curative (C) | 2013-11-16 | 2014-01-15 | COPP + Dacarbazine | N | N | 270012597 | COPP + DACARBAZINE |
| 270018890 | 270008376 | null | 71.4 | Curative (C) | 2017-10-08 | 2017-10-23 | COPP + Dacarbazine | N | null | 270012598 | COPP + DACARBAZINE |
| 270018891 | 270008380 | 1.54 | null | Curative (C) | 2015-10-08 | 2017-03-15 | CETUXIMAB | N | N | 270012612 | CETUXIMAB |
| 270018892 | 270016650 | null | 71.1 | Curative (C) | 2017-11-08 | 2017-12-27 | CETUXIMAB | null | N | 270012660 | CETUXIMAB |
| 270018893 | 270008413 | 1.69 | null | Curative (C) | 2018-06-25 | 2018-07-20 | Escalated BEACOPP | N | null | 270012719 | BEACOPP |
| 270018894 | 270008415 | 1.76 | 54.3 | Curative (C) | 2016-10-04 | 2016-10-04 | COPP + Dacarbazine | N | N | 270012720 | COPP + DACARBAZINE |
| 270018895 | 270013984 | 1.76 | 99.44 | Curative (C) | null | 2016-05-29 | Escalated BEACOPP | 2 | N | 270012723 | BEACOPP |
| 270018896 | 270008424 | 1.42 | 78.8 | Curative (C) | 2017-02-10 | 2017-02-13 | COPP + Dacarbazine | N | null | 270012726 | COPP + DACARBAZINE |
| 270018897 | 270008428 | null | 90 | null | 2014-01-05 | 2014-01-05 | Cetuximab 7 day (Cycle 1) | N | N | 270012737 | CETUXIMAB |
| 270018898 | 270013989 | 0 | 74 | Curative (C) | 2014-05-04 | 2014-05-06 | COPP + Dacarbazine | N | N | 270012753 | COPP + DACARBAZINE |
| 270018899 | 270008436 | 1.77 | 71.4 | Curative (C) | 2013-12-22 | 2013-12-28 | CETUXIMAB | N | N | 270012755 | CETUXIMAB |
| 270018900 | 270008463 | 1.64 | 66 | Curative (C) | 2014-03-11 | 2014-12-31 | HD EuroNet-PHL-C1 COPDAC | 2 | N | 270012830 | TRIAL |